Suppressed bone turnover during alendronate therapy for high-turnover osteoporosis

N Engl J Med. 2006 Nov 9;355(19):2048-50. doi: 10.1056/NEJMc062268.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Alendronate / adverse effects
  • Alendronate / pharmacology*
  • Bone Density / drug effects*
  • Bone Density Conservation Agents / adverse effects
  • Bone Density Conservation Agents / pharmacology*
  • Bone Remodeling / drug effects*
  • Fractures, Bone / etiology
  • Humans
  • Ilium / pathology
  • Male
  • Osteoporosis / drug therapy
  • Osteoporosis / pathology

Substances

  • Bone Density Conservation Agents
  • Alendronate